We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+9.13%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$20.5B
AUM Growth
+$1.31B
Cap. Flow
-$64.5M
Cap. Flow %
-0.31%
Top 10 Hldgs %
30.13%
Holding
1,270
New
254
Increased
410
Reduced
389
Closed
206

Top Sells

Rank Stock Value
1
RY icon
Royal Bank of Canada
RY
+$115M
2
ENB icon
Enbridge
ENB
+$87.8M
3
PFE icon
Pfizer
PFE
+$80.4M
4
CNI icon
Canadian National Railway
CNI
+$78.6M
5
AAPL icon
Apple
AAPL
+$73.1M

Sector Composition

Rank Sector Weight
1 Financials 24.6%
2 Technology 17.8%
3 Industrials 12.95%
4 Communication Services 8.37%
5 Materials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGF.B
776
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$574K ﹤0.01%
37,276
+7,111
+24% +$99.6K
BEKE icon
777
KE Holdings
BEKE
$18.7B
$563K ﹤0.01%
27,977
+12,151
+77% +$249K
CVEO icon
778
Civeo
CVEO
$344M
$563K ﹤0.01%
29,376
-2,891
-9% -$61.8K
PRQR icon
779
ProQR Therapeutics
PRQR
$261M
$560K ﹤0.01%
69,973
+31,614
+82% +$241K
SPSC icon
780
SPS Commerce
SPSC
$2.86B
$559K ﹤0.01%
+3,929
New +$589K
HOMB icon
781
Home BancShares
HOMB
$6.27B
$554K ﹤0.01%
+22,736
New +$560K
RETA
782
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$550K ﹤0.01%
20,842
+12,047
+137% +$932K
MNDT
783
DELISTED
Mandiant, Inc. Common Stock
MNDT
$549K ﹤0.01%
+31,298
New +$550K
AGS
784
DELISTED
PlayAGS
AGS
$548K ﹤0.01%
80,697
-418
-0.5% -$3.2K
WLFC icon
785
Willis Lease Finance
WLFC
$1.15B
$545K ﹤0.01%
43,440
-1,065
-2% -$13.6K
JBLU icon
786
JetBlue
JBLU
$2.19B
$544K ﹤0.01%
+38,174
New +$561K
MOMO
787
Hello Group
MOMO
$850M
$538K ﹤0.01%
+59,961
New +$686K
BW icon
788
Babcock & Wilcox
BW
$1.39B
$536K ﹤0.01%
59,383
-10,900
-16% -$87.3K
MRTN icon
789
Marten Transport
MRTN
$1.24B
$530K ﹤0.01%
+30,906
New +$512K
COHU icon
790
Cohu
COHU
$2.76B
$528K ﹤0.01%
+13,868
New +$475K
NATI
791
DELISTED
National Instruments Corp
NATI
$524K ﹤0.01%
+12,004
New +$510K
TLK icon
792
Telkom Indonesia
TLK
$14.5B
$522K ﹤0.01%
18,003
+9,607
+114% +$261K
GOSS icon
793
Gossamer Bio
GOSS
$83.3M
$517K ﹤0.01%
45,719
-787
-2% -$9.35K
EXPD icon
794
Expeditors International
EXPD
$24.3B
$512K ﹤0.01%
3,809
-28,207
-88% -$3.53M
PCRX icon
795
Pacira BioSciences
PCRX
$924M
$511K ﹤0.01%
+8,485
New +$468K
ADPT icon
796
Adaptive Biotechnologies
ADPT
$3.89B
$505K ﹤0.01%
18,010
-5,564
-24% -$171K
ZUO
797
DELISTED
Zuora, Inc.
ZUO
$505K ﹤0.01%
27,037
-42,220
-61% -$848K
AM icon
798
Antero Midstream
AM
$10.5B
$502K ﹤0.01%
51,819
-321,648
-86% -$3.34M
VMC icon
799
Vulcan Materials
VMC
$36B
$498K ﹤0.01%
2,398
+262
+12% +$50.7K
TLYS icon
800
Tilly's
TLYS
$122M
$491K ﹤0.01%
30,484
-8,564
-22% -$129K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q4 2021 Portfolio in Review

As of Q4 2021, Connor, Clark & Lunn Investment Management (CC&L) held 1,270 positions worth $20.5B, up 6.8% from $19.2B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L)'s Q4 2021 filing shows 254 new, 410 increased, 389 reduced and 206 closed positions. Its largest new stake was Nuvei Corporation Subordinate Voting Shares: 879,610 shares worth $57.1M. The largest sale was Royal Bank of Canada, an estimated $115M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q4 2021 buy was Nuvei Corporation Subordinate Voting Shares: 879,610 shares worth $57.1M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Waste Connections in Q4 2021, an estimated $102M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q4 2021 reduction was Royal Bank of Canada, cutting an estimated $115M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Edwards Lifesciences in Q4 2021, selling an estimated $26.6M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 30% of its $20.5B portfolio in Q4 2021.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 254 new positions and closed 206 in Q4 2021.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 6.8% quarter-over-quarter to $20.5B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2021, filed 10 Feb 2022.